Recent advances in quantitative chimerism analysis

References

• Kolb HJ. Graft-versus-leukemia effects of transplantation and donor lymphocytes. Blood112(12), 4371–4383 (2008).
   PubMed Web of Science ®Google Scholar
• Kolb HJ, Schmid C, Barrett AJ, Schendel DJ. Graft-versus-leukemia reactions in allogeneic chimeras. Blood103(3), 767–776 (2004).
   PubMed Web of Science ®Google Scholar
• Vandenberghe P, Boogaerts MA. Graft-versus-leukemia and graft-versus-lymphoma effects of allogeneic bone marrow transplantation and of allogeneic donor leukocyte transfusions. Ann. Hematol.71(5), 209–217 (1995).
   PubMed Web of Science ®Google Scholar
• Sanchez J, Serrano J, Gomez P et al. Clinical value of immunological monitoring of minimal residual disease in acute lymphoblastic leukaemia after allogeneic transplantation. Br. J. Haematol.116(3), 686–694 (2002).
   PubMed Web of Science ®Google Scholar
• Serrano J, Roman J, Sanchez J et al. Molecular analysis of lineage-specific chimerism and minimal residual disease by RT-PCR of p210(BCR-ABL) and p190(BCR-ABL) after allogeneic bone marrow transplantation for chronic myeloid leukemia: increasing mixed myeloid chimerism and p190(BCR-ABL) detection precede cytogenetic relapse. Blood95(8), 2659–2665 (2000).
   PubMed Web of Science ®Google Scholar
• Uzunel M, Jaksch M, Mattsson J, Ringden O. Minimal residual disease detection after allogeneic stem cell transplantation is correlated to relapse in patients with acute lymphoblastic leukaemia. Br. J. Haematol.122(5), 788–794 (2003).
   PubMedGoogle Scholar
• Rinkevich B. Human natural chimerism: an acquired character or a vestige of evolution? Hum. Immunol.62(6), 651–657 (2001).
   PubMed Web of Science ®Google Scholar
• Baron F, Baker JE, Storb R et al. Kinetics of engraftment in patients with hematologic malignancies given allogeneic hematopoietic cell transplantation after nonmyeloablative conditioning. Blood104(8), 2254–2262 (2004).
   PubMed Web of Science ®Google Scholar
• Baron F, Maris MB, Storer BE et al. High doses of transplanted CD34+ cells are associated with rapid T-cell engraftment and lessened risk of graft rejection, but not more graft-versus-host disease after nonmyeloablative conditioning and unrelated hematopoietic cell transplantation. Leukemia19(5), 822–828 (2005).
   PubMed Web of Science ®Google Scholar
• Bader P, Beck J, Frey A et al. Serial and quantitative analysis of mixed hematopoietic chimerism by PCR in patients with acute leukemias allows the prediction of relapse after allogeneic BMT. Bone Marrow Transplant.21(5), 487–495 (1998).
   PubMed Web of Science ®Google Scholar
• Barrios M, Jimenez-Velasco A, Roman-Gomez J et al. Chimerism status is a useful predictor of relapse after allogeneic stem cell transplantation for acute leukemia. Haematologica88(7), 801–810 (2003).
   PubMed Web of Science ®Google Scholar
• Lamba R, Abella E, Kukuruga D et al. Mixed hematopoietic chimerism at day 90 following allogenic myeloablative stem cell transplantation is a predictor of relapse and survival. Leukemia18(10), 1681–1686 (2004).
   PubMed Web of Science ®Google Scholar
• Bader P, Niethammer D, Willasch A, Kreyenberg H, Klingebiel T. How and when should we monitor chimerism after allogeneic stem cell transplantation? Bone Marrow Transplant.35(2), 107–119 (2005).
   PubMed Web of Science ®Google Scholar
• Kristt D, Israeli M, Narinski R et al. Hematopoietic chimerism monitoring based on STRs: quantitative platform performance on sequential samples. J. Biomol. Tech.16(4), 380–391 (2005).
   PubMedGoogle Scholar
• Kristt D, Stein J, Yaniv I, Klein T. Assessing quantitative chimerism longitudinally: technical considerations, clinical applications and routine feasibility. Bone Marrow Transplant.39(5), 255–268 (2007).
   PubMedGoogle Scholar
• Thiede C, Bornhauser M, Oelschlagel U et al. Sequential monitoring of chimerism and detection of minimal residual disease after allogeneic blood stem cell transplantation (BSCT) using multiplex PCR amplification of short tandem repeat-markers. Leukemia15(2), 293–302 (2001).
   PubMed Web of Science ®Google Scholar
• Reich DE, Schaffner SF, Daly MJ et al. Human genome sequence variation and the influence of gene history, mutation and recombination. Nat. Genetics32(1), 135–142 (2002).
   PubMed Web of Science ®Google Scholar
• Feuk L, Carson AR, Scherer SW. Structural variation in the human genome. Nat. Reviews7(2), 85–97 (2006).
   Google Scholar
• Scherer SW, Lee C, Birney E et al. Challenges and standards in integrating surveys of structural variation. Nat. Genetics39(7 Suppl.), S7–S15 (2007).
   Google Scholar
• Beckman JS, Weber JL. Survey of human and rat microsatellites. Genomics12(4), 627–631 (1992).
   PubMedGoogle Scholar
• Ellegren H. Heterogeneous mutation processes in human microsatellite DNA sequences. Nat. Genetics24(4), 400–402 (2000).
   PubMed Web of Science ®Google Scholar
• Butler JM. Genetics and genomics of core short tandem repeat loci used in human identity testing. J. Forensic Sci.51(2), 253–265 (2006).
   PubMed Web of Science ®Google Scholar
• Butler JM. Short tandem repeat typing technologies used in human identity testing. Biotechniques43(4), ii–v (2007).
   PubMedGoogle Scholar
• Beck O, Seidl C, Lehrnbecher T et al. Quantification of chimerism within peripheral blood, bone marrow and purified leukocyte subsets: comparison of singleplex and multiplex PCR amplification of short tandem repeat (STR) loci. Eur. J. Haematol.76(3), 237–244 (2006).
   PubMed Web of Science ®Google Scholar
• Fernandez-Aviles F, A Urbano-Ispizua, Aymerich M et al. Serial quantification of lymphoid and myeloid mixed chimerism using multiplex PCR amplification of short tandem repeat-markers predicts graft rejection and relapse, respectively, after allogeneic transplantation of CD34+ selected cells from peripheral blood. Leukemia17(3), 613–620 (2003).
   PubMed Web of Science ®Google Scholar
• Koehl U, Beck O, Esser R et al. Quantitative analysis of chimerism after allogeneic stem cell transplantation by PCR amplification of microsatellite markers and capillary electrophoresis with fluorescence detection: the Frankfurt experience. Leukemia17(1), 232–236 (2003).
   PubMedGoogle Scholar
• Sufliarska S, Minarik G, Horakova J et al. Establishing the method of chimerism monitoring after allogeneic stem cell transplantation using multiplex polymerase chain reaction amplification of short tandem repeat markers and amelogenin. Neoplasma54(5), 424–430 (2007).
   PubMed Web of Science ®Google Scholar
• Mills RE, Luttig CT, Larkins CE et al. An initial map of insertion and deletion (INDEL) variation in the human genome. Genome Res.16(9), 1182–1190 (2006).
   PubMed Web of Science ®Google Scholar
• Weber JL, David D, Heil J et al. Human diallelic insertion/deletion polymorphisms. Am. J. Hum. Genet.71(4), 854–862 (2002).
   PubMed Web of Science ®Google Scholar
• Alizadeh M, Bernard M, Danic B et al. Quantitative assessment of hematopoietic chimerism after bone marrow transplantation by real-time quantitative polymerase chain reaction. Blood99(12), 4618–4625 (2002).
   PubMed Web of Science ®Google Scholar
• Jimenez-Velasco A, Barrios M, Roman-Gomez J et al. Reliable quantification of hematopoietic chimerism after allogeneic transplantation for acute leukemia using amplification by real-time PCR of null alleles and insertion/deletion polymorphisms. Leukemia19(3), 336–343 (2005).
   PubMedGoogle Scholar
• Sachidanandam R, Weissman D, Schmidt SC et al. A map of human genome sequence variation containing 1.42 million single nucleotide polymorphisms. Nature409(6822), 928–933 (2001).
   PubMed Web of Science ®Google Scholar
• Kim S, Misra A. SNP genotyping: technologies and biomedical applications. Annu. Rev. Biomed. Eng.9, 289–320 (2007).
   PubMed Web of Science ®Google Scholar
• Sobrino B, Carracedo A. SNP typing in forensic genetics: a review. Methods Mol. Biol.297, 107–126 (2005).
   PubMedGoogle Scholar
• Kaller M, Lundeberg J, Ahmadian A. Arrayed identification of DNA signatures. Expert Rev. Mol. Diagn.7(1), 65–76 (2007).
   PubMed Web of Science ®Google Scholar
• Tindall EA, Speight G, Petersen DC, Padilla EJ, Hayes VM. Novel Plexor SNP genotyping technology: comparisons with TaqMan and homogenous MassEXTEND MALDI-TOF mass spectrometry. Hum. Mutat.28(9), 922–927 (2007).
   PubMedGoogle Scholar
• Khan F, Agarwal A, Agrawal S. Significance of chimerism in hematopoietic stem cell transplantation: new variations on an old theme. Bone Marrow Transplant.34(1), 1–12 (2004).
   PubMed Web of Science ®Google Scholar
• Thiede C. Diagnostic chimerism analysis after allogeneic stem cell transplantation: new methods and markers. Am. J. Pharmacogenomics4(3), 177–187 (2004).
   PubMedGoogle Scholar
• Acquaviva C, Duval M, Mirebeau D, Bertin R, Cave H. Quantitative analysis of chimerism after allogeneic stem cell transplantation by PCR amplification of microsatellite markers and capillary electrophoresis with fluorescence detection: the Paris–Robert Debre experience. Leukemia17(1), 241–246 (2003).
   PubMed Web of Science ®Google Scholar
• Chalandon Y, Vischer S, Helg C, Chapuis B, Roosnek E. Quantitative analysis of chimerism after allogeneic stem cell transplantation by PCR amplification of microsatellite markers and capillary electrophoresis with fluorescence detection: the Geneva experience. Leukemia17(1), 228–231 (2003).
   PubMedGoogle Scholar
• Hancock JP, Goulden NJ, Oakhill A, Steward CG. Quantitative analysis of chimerism after allogeneic bone marrow transplantation using immunomagnetic selection and fluorescent microsatellite PCR. Leukemia17(1), 247–251 (2003).
   PubMedGoogle Scholar
• Hochberg EP, Miklos DB, Neuberg D et al. A novel rapid single nucleotide polymorphism (SNP)-based method for assessment of hematopoietic chimerism after allogeneic stem cell transplantation. Blood101(1), 363–369 (2003).
   PubMed Web of Science ®Google Scholar
• Kreyenberg H, Holle W, Mohrle S, Niethammer D, Bader P. Quantitative analysis of chimerism after allogeneic stem cell transplantation by PCR amplification of microsatellite markers and capillary electrophoresis with fluorescence detection: the Tuebingen experience. Leukemia17(1), 237–240 (2003).
   PubMedGoogle Scholar
• Scharf SJ, Smith AG, Hansen JA, McFarland C, Erlich HA. Quantitative determination of bone marrow transplant engraftment using fluorescent polymerase chain reaction primers for human identity markers. Blood85(7), 1954–1963 (1995).
   PubMed Web of Science ®Google Scholar
• Schraml E, Daxberger H, Watzinger F, Lion T. Quantitative analysis of chimerism after allogeneic stem cell transplantation by PCR amplification of microsatellite markers and capillary electrophoresis with fluorescence detection: the Vienna experience. Leukemia17(1), 224–227 (2003).
   PubMed Web of Science ®Google Scholar
• Thiede C, Bornhauser M, Ehninger G. Evaluation of STR informativity for chimerism testing – comparative analysis of 27 STR systems in 203 matched related donor recipient pairs. Leukemia18(2), 248–254 (2004).
   PubMed Web of Science ®Google Scholar
• Ariffin H, Daud SS, Mohamed Z et al. Evaluation of two short tandem repeat multiplex systems for post-haematopoietic stem cell transplantation chimerism analysis. Singapore Med. J.48(4), 333–337 (2007).
   PubMedGoogle Scholar
• Oliver DH, Thompson RE, Griffin CA, Eshleman JR. Use of single nucleotide polymorphisms (SNP) and real-time polymerase chain reaction for bone marrow engraftment analysis. J. Mol. Diagn.2(4), 202–208 (2000).
   PubMed Web of Science ®Google Scholar
• Fredriksson M, Barbany G, Liljedahl U et al. Assessing hematopoietic chimerism after allogeneic stem cell transplantation by multiplexed SNP genotyping using microarrays and quantitative analysis of SNP alleles. Leukemia18(2), 255–266 (2004).
   PubMedGoogle Scholar
• Gineikiene E, Stoskus M, Griskevicius L. Single nucleotide polymorphism-based system improves the applicability of quantitative PCR for chimerism monitoring. J. Mol. Diagn.11(1), 66–74 (2009).
   PubMedGoogle Scholar
• Harries LW, Wickham CL, Evans JC et al. Analysis of haematopoietic chimaerism by quantitative real-time polymerase chain reaction. Bone Marrow Transplant.35(3), 283–290 (2005).
   PubMedGoogle Scholar
• Koldehoff M, Steckel NK, Hlinka M, Beelen DW, Elmaagacli AH. Quantitative analysis of chimerism after allogeneic stem cell transplantation by real-time polymerase chain reaction with single nucleotide polymorphisms, standard tandem repeats, and Y-chromosome-specific sequences. Am. J. Hematol.81(10), 735–746 (2006).
   PubMed Web of Science ®Google Scholar
• Martinez-Lopez J, Crooke A, Grande S et al. Real-time PCR quantification of haematopoietic chimerism after transplantation: a comparison between TaqMan and hybridization probes technologies. Int. J. Lab. Hematol.: 10.1111/j.1751-553X.2009.01166.x (2009) (Epub ahead of print).
   PubMedGoogle Scholar
• Eshel R, Vainas O, Shpringer M, Naparstek E. Highly sensitive patient-specific real-time PCR SNP assay for chimerism monitoring after allogeneic stem cell transplantation. Lab. Hematol.12(1), 39–46 (2006).
   PubMedGoogle Scholar
• Willasch A, Schneider G, Reincke BS et al. Sequence polymorphism systems for quantitative real-time polymerase chain reaction to characterize hematopoietic chimerism-high informativity and sensitivity as well as excellent reproducibility and precision of measurement. Lab. Hematol.13(3), 73–84 (2007).
   PubMedGoogle Scholar
• Borrill V, Schlaphoff T, E du Toit et al. The use of short tandem repeat polymorphisms for monitoring chimerism following bone marrow transplantation: a short report. Hematology13(4), 210–214 (2008).
   PubMed Web of Science ®Google Scholar
• Lion T. Summary: reports on quantitative analysis of chimerism after allogeneic stem cell transplantation by PCR amplification of microsatellite markers and capillary electrophoresis with fluorescence detection. Leukemia17(1), 252–254 (2003).
   PubMedGoogle Scholar
• Lobashevsky AL, Senkbeil RW, Townsend JE, Mink CA, Thomas JM. Quantitative analysis of chimerism using a short tandem repeat method on a fluorescent automated DNA sequencer. Clin. Lab. Haematol.28(1), 40–49 (2006).
   PubMedGoogle Scholar
• Fan H, Chu JY. A brief review of short tandem repeat mutation. Genomics Proteomics Bioinformatics5(1), 7–14 (2007).
   PubMedGoogle Scholar
• Walsh PS, Fildes NJ, Reynolds R. Sequence analysis and characterization of stutter products at the tetranucleotide repeat locus vWA. Nucleic Acids Res.24(14), 2807–2812 (1996).
   PubMed Web of Science ®Google Scholar
• Chen DP, Tseng CP, Tsai SH et al. Systematic analysis of stutters to enhance the accuracy of chimerism testing. Ann. Clin. Lab. Sci.38(3), 264–272 (2008).
   PubMedGoogle Scholar
• Schraml E, Lion T. Interference of dye-associated fluorescence signals with quantitative analysis of chimerism by capillary electrophoresis. Leukemia17(1), 221–223 (2003).
   PubMedGoogle Scholar
• Walsh PS, Erlich HA, Higuchi R. Preferential PCR amplification of alleles: mechanisms and solutions. PCR Methods Appl.1(4), 241–250 (1992).
   PubMedGoogle Scholar
• Watzinger F, Lion T, Steward C. The RSD code: proposal for a nomenclature of allelic configurations in STR-PCR-based chimerism testing after allogeneic stem cell transplantation. Leukemia20(8), 1448–1452 (2006).
   PubMedGoogle Scholar
• Madeo D, Cappellari A, Castaman G, Raimondi R, Rodeghiero F. Multiplex amplification and fluorimetric detection of short tandem repeats for mixed chimerism after bone marrow transplant. Leukemia Lymphoma44(8), 1395–1404 (2003).
   PubMed Web of Science ®Google Scholar
• Sellathamby S, Balasubramanian P, Sivalingam S et al. Developing an algorithm of informative markers for evaluation of chimerism after allogeneic bone marrow transplantation. Bone Marrow Transplant.37(8), 751–755 (2006).
   PubMedGoogle Scholar
• Talwar S, Khan F, Nityanand S, Agrawal S. Chimerism monitoring following allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant.39(9), 529–535 (2007).
   PubMedGoogle Scholar
• Willasch A, Eing S, Weber G et al. Enrichment of cell subpopulations applying automated MACS technique: purity, recovery and applicability for PCR-based chimerism analysis. Bone Marrow Transplant. DOI: 10.1038/bmt.2009.89 (2009) (Epub ahead of print).
   PubMedGoogle Scholar
• Chen DP, Tsai SH, Tseng CP et al. Bone marrow transplant relapse with loss of an allele. Clin. Chim. Acta387(1–2), 161–164 (2008).
   PubMedGoogle Scholar
• Dunn T, Allen R, Bates F et al. Cytogenetic changes associated with myelodysplastic syndrome affecting bone marrow engraftment analysis. J. Mol. Diagn.8(2), 288–294 (2006).
   PubMedGoogle Scholar
• Seywerd K, Allen RA, Dunn ST. Primer site polymorphisms: potential implications for bone marrow engraftment monitoring. Genet. Test. Mol. Biomarkers13(3), 415–419 (2009).
   PubMedGoogle Scholar
• Schichman SA, Lin P, Gilbrech LJ et al. Bone marrow transplant engraftment analysis with loss of an informative allele. J. Mol. Diagn.4(4), 230–232 (2002).
   PubMed Web of Science ®Google Scholar
• Swierczynski SL, Hafez MJ, Philips J et al. Bone marrow engraftment analysis after granulocyte transfusion. J. Mol. Diagn.7(3), 422–426 (2005).
   PubMedGoogle Scholar
• Butler JM, Schoske R, Vallone PM et al. A novel multiplex for simultaneous amplification of 20 Y chromosome STR markers. Forensic Sci. Int.129(1), 10–24 (2002).
   PubMed Web of Science ®Google Scholar
• Rodig H, Roewer L, Gross A et al. Evaluation of haplotype discrimination capacity of 35 Y-chromosomal short tandem repeat loci. Forensic Sci. Int.174(2–3), 182–188 (2008).
   PubMed Web of Science ®Google Scholar
• Schoske R, Vallone PM, Kline MC, Redman JW, Butler JM. High-throughput Y-STR typing of U.S. populations with 27 regions of the Y chromosome using two multiplex PCR assays. Forensic Sci. Int.139(2–3), 107–121 (2004).
   PubMedGoogle Scholar
• Schoske R, Vallone PM, Ruitberg CM, Butler JM. Multiplex PCR design strategy used for the simultaneous amplification of 10 Y chromosome short tandem repeat (STR) loci. Anal. Bioanal. Chem.375(3), 333–343 (2003).
   PubMedGoogle Scholar
• Vallone PM, Hill CR, Butler JM. Demonstration of rapid multiplex PCR amplification involving 16 genetic loci. Forensic Sci. Int.3(1), 42–45 (2008).
   Google Scholar
• Butler JM. Constructing STR multiplex assays. Methods Mol. Biol.297, 53–66 (2005).
   PubMedGoogle Scholar
• Kristt D, Stein J, Yaniv I, Klein T. Interactive ChimerTrack software facilitates computation, visual displays and long-term tracking of chimeric status based on STRs. Leukemia18(5), 909–911 (2004).
   PubMedGoogle Scholar
• Kristt D, Klein T. Reliability of quantitative chimerism results: assessment of sample performance using novel parameters. Leukemia20(6), 1169–1172 (2006).
   PubMedGoogle Scholar
• Kristt D, Stein J, Klein T. Frontiers of stem cell transplantation monitoring: capturing graft dynamics through routine longitudinal chimerism analysis. Isr. Med. Assoc. J.9(3), 159–162 (2007).
   PubMedGoogle Scholar
• Maas F, Schaap N, Kolen S et al. Quantification of donor and recipient hemopoietic cells by real-time PCR of single nucleotide polymorphisms. Leukemia17(3), 621–629 (2003).
   PubMedGoogle Scholar
• Newton CR, Graham A, Heptinstall LE et al. Analysis of any point mutation in DNA. The amplification refractory mutation system (ARMS). Nucleic Acids Res.17(7), 2503–2516 (1989).
   PubMed Web of Science ®Google Scholar
• Newton CR, Summers C, Heptinstall LE et al. Genetic analysis in cystic fibrosis using the amplification refractory mutation system (ARMS): the J3.11 MspI polymorphism. J. Med. Genet.28(4), 248–251 (1991).
   PubMed Web of Science ®Google Scholar
• Ayyadevara S, Thaden JJ, Shmookler RJ. Discrimination of primer 3´-nucleotide mismatch by taq DNA polymerase during polymerase chain reaction. Anal. Biochem.284(1), 11–18 (2000).
   PubMed Web of Science ®Google Scholar
• Masmas TN, Madsen HO, Petersen SL et al. Evaluation and automation of hematopoietic chimerism analysis based on real-time quantitative polymerase chain reaction. Biol. Blood Marrow Transplant.11(7), 558–566 (2005).
   PubMedGoogle Scholar
• Kutyavin IV, Afonina IA, Mills A et al. 3´-minor groove binder-DNA probes increase sequence specificity at PCR extension temperatures. Nucleic Acids Res.28(2), 655–661 (2000).
   PubMed Web of Science ®Google Scholar
• Johnson MP, Haupt LM, Griffiths LR. Locked nucleic acid (LNA) single nucleotide polymorphism (SNP) genotype analysis and validation using real-time PCR. Nucleic Acids Res.32(6), E55 (2004).
   PubMed Web of Science ®Google Scholar
• Hazbon MH, Alland D. Hairpin primers for simplified single-nucleotide polymorphism analysis of Mycobacterium tuberculosis and other organisms. J. Clin. Microbiol.42(3), 1236–1242 (2004).
   PubMedGoogle Scholar
• Hiratsuka M, Tsukamoto N, Konno Y et al. Forensic assessment of 16 single nucleotide polymorphisms analyzed by hybridization probe assay. Tohoku J. Exp. Med.207(4), 255–261 (2005).
   PubMedGoogle Scholar
• Campregher PV, Gooley T, Scott BL et al. Results of donor lymphocyte infusions for relapsed myelodysplastic syndrome after hematopoietic cell transplantation. Bone Marrow Transplant.40(10), 965–971 (2007).
   PubMedGoogle Scholar
• Castro FA, Palma PV, Morais FR, Voltarelli JC. Immunological effects of donor lymphocyte infusion in patients with chronic myelogenous leukemia relapsing after bone marrow transplantation. Braz. J. Med. Biol. Res.37(2), 201–206 (2004).
   PubMedGoogle Scholar
• Cummins M, Cwynarski K, Marktel S et al. Management of chronic myeloid leukaemia in relapse following donor lymphocyte infusion induced remission: a retrospective study of the Clinical Trials Committee of the British Society of Blood & Marrow Transplantation (BSBMT). Bone Marrow Transplant.36(12), 1065–1069 (2005).
   PubMed Web of Science ®Google Scholar
• Depil S, Deconinck E, Milpied N et al. Donor lymphocyte infusion to treat relapse after allogeneic bone marrow transplantation for myelodysplastic syndrome. Bone Marrow Transplant.33(5), 531–534 (2004).
   PubMed Web of Science ®Google Scholar
• Loren AW, Porter DL. Donor leukocyte infusions after unrelated donor hematopoietic stem cell transplantation. Curr. Opin. Oncol.18(2), 107–114 (2006).
   PubMed Web of Science ®Google Scholar
• Loren AW, Porter DL. Donor leukocyte infusions for the treatment of relapsed acute leukemia after allogeneic stem cell transplantation. Bone Marrow Transplant.41(5), 483–493 (2008).
   PubMed Web of Science ®Google Scholar
• Schmid C, Labopin M, Nagler A et al. Donor lymphocyte infusion in the treatment of first hematological relapse after allogeneic stem-cell transplantation in adults with acute myeloid leukemia: a retrospective risk factors analysis and comparison with other strategies by the EBMT Acute Leukemia Working Party. J. Clin. Oncol.25(31), 4938–4945 (2007).
   PubMed Web of Science ®Google Scholar
• Petersen SL. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning. Danish Medical Bulletin54(2), 112–139 (2007).
   PubMed Web of Science ®Google Scholar
• Choi SJ, Lee JH, Lee JH et al. Treatment of relapsed acute lymphoblastic leukemia after allogeneic bone marrow transplantation with chemotherapy followed by G-CSF-primed donor leukocyte infusion: a prospective study. Bone Marrow Transplant.36(2), 163–169 (2005).
   PubMed Web of Science ®Google Scholar
• Choi SJ, Lee JH, Lee JH et al. Treatment of relapsed acute myeloid leukemia after allogeneic bone marrow transplantation with chemotherapy followed by G-CSF-primed donor leukocyte infusion: a high incidence of isolated extramedullary relapse. Leukemia18(11), 1789–1797 (2004).
   PubMed Web of Science ®Google Scholar
• Shimoni A, Nagler A. Non-myeloablative stem cell transplantation (NST): chimerism testing as guidance for immune-therapeutic manipulations. Leukemia15(12), 1967–1975 (2001).
   PubMed Web of Science ®Google Scholar
• Mapara MY, Kim YM, Marx J, Sykes M. Donor lymphocyte infusion-mediated graft-versus-leukemia effects in mixed chimeras established with a nonmyeloablative conditioning regimen: extinction of graft-versus-leukemia effects after conversion to full donor chimerism. Transplantation76(2), 297–305 (2003).
   PubMed Web of Science ®Google Scholar
• Canitrot Y, Falinski R, Louat T et al. p210 BCR/ABL kinase regulates nucleotide excision repair (NER) and resistance to UV radiation. Blood102(7), 2632–2637 (2003).
   PubMed Web of Science ®Google Scholar
• Chng WJ, Ketterling RP, Fonseca R. Analysis of genetic abnormalities provides insights into genetic evolution of hyperdiploid myeloma. Genes Chromosomes Cancer45(12), 1111–1120 (2006).
   PubMed Web of Science ®Google Scholar
• Koptyra M, Falinski R, Nowicki MO et al. BCR/ABL kinase induces self-mutagenesis via reactive oxygen species to encode imatinib resistance. Blood108(1), 319–327 (2006).
   PubMed Web of Science ®Google Scholar
• Mullighan CG, Downing JR. Genome-wide profiling of genetic alterations in acute lymphoblastic leukemia: recent insights and future directions. Leukemia(2009).
   PubMedGoogle Scholar
• Mullighan CG, Phillips LA, Su X et al. Genomic analysis of the clonal origins of relapsed acute lymphoblastic leukemia. Science322(5906), 1377–1380 (2008).
   PubMed Web of Science ®Google Scholar
• Nowicki MO, Falinski R, Koptyra M et al. BCR/ABL oncogenic kinase promotes unfaithful repair of the reactive oxygen species-dependent DNA double-strand breaks. Blood104(12), 3746–3753 (2004).
   PubMed Web of Science ®Google Scholar
• Skorski T. BCR/ABL regulates response to DNA damage: the role in resistance to genotoxic treatment and in genomic instability. Oncogene21(56), 8591–8604 (2002).
   PubMed Web of Science ®Google Scholar
• Skorski T. BCR/ABL, DNA damage and DNA repair: implications for new treatment concepts. Leukemia Lymphoma49(4), 610–614 (2008).
   PubMed Web of Science ®Google Scholar
• Downing JR, Mullighan CG. Tumor-specific genetic lesions and their influence on therapy in pediatric acute lymphoblastic leukemia. Hematology Am. Soc. Hematol. Educ. Program118–122, 508 (2006).
   Google Scholar
• Krog GR, Clausen FB, Dziegiel MH. Quantitation of RHD by real-time polymerase chain reaction for determination of RHD zygosity and RHD mosaicism/chimerism: an evaluation of four quantitative methods. Transfusion47(4), 715–722 (2007).
   PubMedGoogle Scholar
• Waterfall CM, Cobb BD. Single tube genotyping of sickle cell anaemia using PCR-based SNP analysis. Nucleic Acids Res.29(23), E119 (2001).
   PubMed Web of Science ®Google Scholar
• Sanchez JJ, Borsting C, Balogh K et al. Forensic typing of autosomal SNPs with a 29 SNP-multiplex--results of a collaborative EDNAP exercise. Forensic Sci. Int.2(3), 176–183 (2008).
   Google Scholar
• Sanchez JJ, Borsting C, Morling N. Typing of Y chromosome SNPs with multiplex PCR methods. Methods Mol. Biol.297, 209–228 (2005).
   PubMedGoogle Scholar
• Sanchez JJ, Phillips C, Borsting C et al. A multiplex assay with 52 single nucleotide polymorphisms for human identification. Electrophoresis27(9), 1713–1724 (2006).
   PubMed Web of Science ®Google Scholar
• Butler JM, Coble MD, Vallone PM. STRs vs. SNPs: thoughts on the future of forensic DNA testing. Forensic Sci. Med. Pathol.3, 200–205 (2007).
   PubMedGoogle Scholar
• Bader P, Kreyenberg H, Hoelle W et al. Increasing mixed chimerism is an important prognostic factor for unfavorable outcome in children with acute lymphoblastic leukemia after allogeneic stem-cell transplantation: possible role for pre-emptive immunotherapy? J. Clin. Oncol.22(9), 1696–1705 (2004).
   PubMed Web of Science ®Google Scholar
• Bader P, Kreyenberg H, Hoelle W et al. Increasing mixed chimerism defines a high-risk group of childhood acute myelogenous leukemia patients after allogeneic stem cell transplantation where pre-emptive immunotherapy may be effective. Bone Marrow Transplant.33(8), 815–821 (2004).
   PubMed Web of Science ®Google Scholar
• Bader P, Niemeyer C, Willasch A et al. Children with myelodysplastic syndrome (MDS) and increasing mixed chimaerism after allogeneic stem cell transplantation have a poor outcome which can be improved by pre-emptive immunotherapy. Brit. J. Haematol.128(5), 649–658 (2005).
   PubMedGoogle Scholar
• Horn B, Soni S, Khan S et al. Feasibility study of preemptive withdrawal of immunosuppression based on chimerism testing in children undergoing myeloablative allogeneic transplantation for hematologic malignancies. Bone Marrow Transplant.43(6), 469–476 (2009).
   PubMedGoogle Scholar